Scholar Rock Holding

General Information
Business:

 

We are a biopharmaceutical company focused on the discovery and development of innovative medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. Our newly elucidated understanding of the molecular mechanisms of growth factor activation enabled us to develop a proprietary platform for the discovery and development of monoclonal antibodies that locally and selectively target these signaling proteins at the cellular level. We believe this approach, acting in the disease microenvironment, avoids the historical challenges associated with inhibiting growth factors for therapeutic effect. We believe our focus on biologically validated growth factors may facilitate a more efficient development path.

Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Employees: 50
Founded: 2017
Contact Information
Address 620 Memorial Drive, 2nd Floor, Cambridge, MA 02139, US
Phone Number (857) 259-3860
Web Address http://www.scholarrock.com
View Prospectus: Scholar Rock Holding
Financial Information
Market Cap $342.2mil
Revenues $0.0 mil (last 12 months)
Net Income $-29.2 mil (last 12 months)
IPO Profile
Symbol SRRK
Exchange NASDAQ
Shares (millions): 5.4
Price range $14.00 - $14.00
Est. $ Volume $75.0 mil
Manager / Joint Managers Jefferies/ Cowen/ BMO Capital Markets
CO-Managers Wedbush PacGrow
Expected To Trade: 5/24/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change